Evidence map›Paper›PMID 34397707›Full record

Observational studyMedicine2021

Screening cardiovascular risk factors of diabetes patients in the primary diabetes clinics.

Lingwang An, Yanlei Wang, Chenxiang Cao, Tao Chen, Yonghong Zhang, Linhui Chen, Shuhong Ren, Manni Tang, Fenglian Ma, Xianglan Li and 4 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03707379 (The Effect of Share Care Model in the Improvement of Diabetes Management), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03707379 unknown statusnot on this map

The Effect of Share Care Model in the Improvement of Diabetes Management

Typeobservational_patient_registrySponsorBeijing Tsinghua Chang Gung HospitalRan2016 to 2026Enrolled3,500ConditionsDiabetes Mellitus, Type 2
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Lingwang AnBeijing Ruijing Diabetes Hospital, Beijing.
Yanlei WangBeijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University.
Chenxiang CaoBeijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University.
Tao ChenChengdu Ryan Diabetes Hospital, Chengdu.
Yonghong ZhangTaiyuan Diabetes Hospital, Taiyuan.
Linhui ChenTaiyuan Diabetes Hospital, Taiyuan.
Shuhong RenLanzhou Ruijing Diabetes Hospital, Lanzhou.
Manni TangChengdu Ryan Diabetes Hospital, Chengdu.
Fenglian MaLanzhou Ruijing Diabetes Hospital, Lanzhou.
Xianglan LiBeijing Ruijing Diabetes Hospital, Beijing.
Shuang YuanHeilongjiang Ruijing Diabetes Hospital, Harbin, Heilongjiang, China.
Wenhui ZhaoBeijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University.
Yaujiunn LeeLee's Clinic, No. 130, Min-Zu Rd, Pingtung, Taiwan.
Jianzhong XiaoBeijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University.ORCID 0000-0001-8449-6346
Diabetes Australia · AUBeijing Tsinghua Chang Gung Hospital · CNNational Pingtung University · TW

Funding

Beijing Tsinghua Changgung Hospital Fund 12016C6007
6 · The paper itself

Abstract

abstractTo evaluate the atherosclerotic cardiovascular diseases (ASCVD) risk factors in type 2 diabetes patients from the primary diabetes clinics for further comprehensive intervention in China.A cross-sectional study was conducted in 5 primary diabetes chain hospitals in Beijing, Lanzhou, Harbin, Chengdu, and Taiyuan in continuous patients with type 2 diabetes from March 2016 to December 2019. The data collected at the first visit were analyzed, and proportions of patients reached the targets (glycosylated hemoglobin [HbA1c] < 7%, blood pressure < 130/80 mm Hg, and low-density lipoprotein cholesterol [LDL-C] < 2.6mmol/l) were calculated. The clinical characteristics and the associated factors with achievement in HbA1c, blood pressure, and LDL-C targets were analyzed.A total of 20,412 participants, including 11,353 men (55.6%), with an average age of (59.4 ± 10.4) years were enrolled. Nearly 95% diabetes had one or more ASCVD risk factors other than hyperglycemia. The control rates of HbA1c, blood pressure, and LDL-C were 26.5%, 27.8%, and 42.6%, respectively. Only 4.1% patients achieved all 3 targets. Nearly 95% patients had one or more ASCVD risk factors other than hyperglyciemia. Diabetes duration, family history, and overweight/obesity were associated with the number of aggregated ASCVD risk factors. The patients with older age, no overweight/obesity, not smoking, less ASCVD risk factors, and having special diabetes care insurance (Chengdu) were associated with a higher control rates.To deal with poor control status, global management of ASCVD risk factors, weight loss, and smoking cessation must be emphasized in the primary diabetes care settings. Special diabetes care insurance should be advocated.Current ClinicalTrial.gov protocol ID NCT03707379. Date of Registration: October 16, 2018. https://clinicaltrials.gov.

Indexed as

Heart Disease Risk FactorsCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMiddle Aged

Identifiers

PMID34397707
PMCPMC8322505
OpenAlexW3107753547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.